Construction of the DSS-Induced Colitis Model

The DSS-induced colitis model is a widely accepted experimental method used to simulate human inflammatory bowel disease for preclinical research. This model is favored for its simplicity, reproducibility, and ability to mimic the pathological features of ulcerative colitis. Understanding the precise construction and evaluation of this model is essential for researchers investigating gastrointestinal inflammation and therapeutic interventions.

Technical Overview

Dextran Sulfate Sodium (DSS) is a sulfated polysaccharide of variable molecular weight that induces acute and chronic colitis in rodents. The administration of DSS in drinking water disrupts the intestinal mucosal barrier, leading to the infiltration of inflammatory cells and the development of ulcerations. This model is particularly valuable because it recapitulates many clinical and histopathological features of human ulcerative colitis, including diarrhea, rectal bleeding, and weight loss. The severity of the induced colitis can be controlled by adjusting the molecular weight of DSS, its concentration in drinking water, and the duration of administration.

Testing Samples

Experimental Animals

The most common subjects for this model are specific pathogen-free (SPF) mice and rats. Strains such as C57BL/6 and BALB/c are frequently utilized, though their susceptibility to DSS varies significantly. C57BL/6 mice are often considered resistant, requiring higher concentrations of DSS, while BALB/c mice are more susceptible. Usually, animals aged 6 to 10 weeks are selected to ensure consistent growth and immune response. Both male and female animals can be used, but sex-based differences in inflammatory response should be considered during experimental design.

Testing Items

To evaluate the success of the model and the severity of the colitis, researchers measure a combination of clinical, macroscopic, and microscopic parameters. These metrics provide a comprehensive view of the disease progression.

• Disease Activity Index (DAI): A composite score calculated based on weight loss, stool consistency, and the presence of fecal blood.
• Colon Length Measurement: Shortening of the colon is a macroscopic marker of inflammation severity.
• Histopathological Scoring: Microscopic evaluation of tissue sections to assess epithelial damage, crypt loss, and inflammatory cell infiltration.
• Myeloperoxidase (MPO) Activity: A quantitative measure of neutrophil infiltration in the colon tissue.

Testing Methods

Model Induction Protocol

The standard protocol involves dissolving DSS powder in autoclaved drinking water at a specific concentration, typically ranging from 1% to 5% depending on the desired severity and animal strain. The DSS solution is provided ad libitum to the animals for a defined period, usually 5 to 7 days for acute colitis. The control group receives normal drinking water without DSS. The water bottles should be changed every two days to ensure the chemical stability of the solution. Fresh solution preparation is critical to prevent microbial growth.

Sample Collection and Analysis

At the end of the experimental period, animals are euthanized, and the entire colon is excised from the cecum to the anus. The colon is measured, opened longitudinally, and washed with cold phosphate-buffered saline (PBS). Tissue samples are then fixed in 10% neutral buffered formalin for histology or snap-frozen in liquid nitrogen for molecular analysis, such as qPCR or ELISA, to quantify inflammatory cytokines like TNF-alpha, IL-6, and IL-1beta.

Applications

The DSS-induced colitis model serves as a foundational tool in biomedical research with broad applications in gastroenterology.

• Drug Screening: It is extensively used to evaluate the efficacy of novel anti-inflammatory compounds and therapeutic agents for inflammatory bowel disease.
• Pathogenesis Studies: Researchers utilize this model to investigate the role of immune cells, cytokines, and the gut microbiota in the development of intestinal inflammation.
• Genetic Studies: The model is often combined with gene knockout or transgenic animals to understand the function of specific genes in mucosal immunity and barrier function.
• Prebiotic and Probiotic Testing: Scientists assess the protective effects of dietary supplements and microbiome modulators on intestinal health.

FAQ

What factors most influence the reproducibility of the DSS colitis model?

Reproducibility is heavily influenced by the molecular weight of the DSS (typically 36-50 kDa is preferred), the specific batch of DSS used, the hygiene status of the animal facility, and the genetics of the mouse strain. It is highly recommended to use DSS with a specified molecular weight range and to perform a pilot study to calibrate the concentration for a specific batch.

How does the DSS model differ from the TNBS model?

The DSS model primarily mimics ulcerative colitis, characterized by superficial mucosal inflammation, whereas the TNBS (Trinitrobenzene sulfonic acid) model induces a transmural inflammation similar to Crohn's disease. Additionally, DSS is administered orally via drinking water, which is non-invasive, while TNBS requires intrarectal instillation, often under anesthesia.

Why is colon shortening considered a reliable marker?

Colon shortening occurs due to extensive edema, inflammatory cell infiltration, and muscle thickening resulting from the inflammatory process. It correlates well with the Disease Activity Index and histopathological scores, providing a quick and objective macroscopic measurement of disease severity.